Tregs CD25 CXCL9 in Vitiligo
NCT05569096 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 40
Last updated 2022-10-06
Summary
Clinical significance of circulating T regulatory cells , soluble CD25 and CXCL9 to assess disease activity of vitiligo.
Conditions
- Vitiligo
- CD25 Deficiency
- Chemokine (C-X-C Motif)
- Tregs
Interventions
- DIAGNOSTIC_TEST
-
ELIZA , Flowcytometry
CD25 , CXCL9 by ELISA. T cell population , T regulatory cells by Flow cytometry.
Sponsors & Collaborators
-
Assiut University
lead OTHER
Eligibility
- Min Age
- 15 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2024-01-31
- Primary Completion
- 2025-01-31
- Completion
- 2026-01-31
More Related Trials
-
Discovery and Validation of Proteogenomic Biomarker Panels in Liver Transplant Recipients
NCT01672164 ·Status: COMPLETED
-
Study of T Cell Phenotype Activation Pathway in Human Alcoholic Liver Disease
NCT00610597 ·Status: COMPLETED
-
Autoimmune Hepatitis Study
NCT00286663 ·Status: TERMINATED
-
Role of Regulatory T Cells in Pathogenesis of Primary IgA Nephropathy
NCT00521508 ·Status: COMPLETED ·Phase: NA
-
Characterization of Autoreactive b Lymphocytes in Autoimmune Diseases and Immune Deficiencies
NCT07251179 ·Status: NOT_YET_RECRUITING
-
FGL2/Fibroleukin and Hepatitis C Virus Infection: A Predictor of Response to Antiviral Therapy
NCT00606528 ·Status: COMPLETED
-
Interest of Follicular Helper Lymphocytes / Regulatory Follicular Helper Lymphocytes Ratio in IgA Nephropathy
NCT05791162 ·Status: RECRUITING ·Phase: NA
-
Impaired Type I IFN Immunity Due to Autoantibodies or a Genetic Defect: a Prospective National Cohort
NCT06762002 ·Status: RECRUITING
-
FGL2/Fibroleukin and Hepatitis C Virus Recurrence Post Liver Transplantation
NCT00701272 ·Status: UNKNOWN
-
Cytokines and the Risk of Infection in Liver Cirrhosis
NCT00857181 ·Status: TERMINATED
-
Prediction of Hepatitis C Recurrence in Liver Transplant Recipients
NCT00867243 ·Status: TERMINATED
-
Differential Gene Expression of Liver Tissue and Blood From Individuals With Chronic Viral Hepatitis
NCT00160940 ·Status: UNKNOWN
-
Role of NGAL in Vitiligo
NCT05290077 ·Status: UNKNOWN ·Phase: NA
-
Fibroscan to Guide Post Transplant Immunosuppression Minimization
NCT07206277 ·Status: RECRUITING ·Phase: NA
-
Immunogenetic Mechanisms in Behcet's Disease
NCT01109433 ·Status: TERMINATED
-
How Sirtuin Levels Change During Behçet Disease
NCT06266247 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Follicular Helper T Cells: Biological Marker and Involvement in the Physiopathology of the IgG4-related Disease
NCT02899039 ·Status: COMPLETED ·Phase: NA
-
Severe PID With Lymphoproliferation and Neutropenia
NCT03427593 ·Status: COMPLETED ·Phase: NA
-
Genetic Polymorphisms of Interleukin-10 and TNF-α on Outcome of HCV-Related Chronic Liver Disease
NCT00630006 ·Status: UNKNOWN ·Phase: NA
-
Complement C5a Receptors in Hidradenitis Suppurativa
NCT04251663 ·Status: COMPLETED
-
Study of Clinical Features of Patients With Autoimmune Liver Disease Complicated With Covid-19 and the Immune Mechanism Affecting Prognosis
NCT06099626 ·Status: UNKNOWN
-
Studies of the Natural History, Pathogenesis, and Outcome of Idiopathic Systemic Vasculitis
NCT02257866 ·Status: RECRUITING
-
Inflammatory Responses in Normal Volunteers and Patients With Abnormal Immune Responses
NCT00001257 ·Status: TERMINATED
-
The Immune Tolerance Mechanism Induced by IL-17-producing Regulatory T Cells in the Orthotopic Liver Transplant Recipients With Aspergillosis
NCT01117077 ·Status: UNKNOWN
-
Prospective Studies on Immunopathogenesis of Liver Fibrosis
NCT04943978 ·Status: RECRUITING